Indikace očkování proti tetanu, záškrtu a černému kašli vakcínou obsahující acelulární pertusovou složku // SOLEN

Pediatria pre prax 2/2004

Indikace očkování proti tetanu, záškrtu a černému kašli vakcínou obsahující acelulární pertusovou složku

INDICATIONS FOR VACCINATION AGAINST TETANUS, DIPHTHERIA AND PERTUSSIS BY VACCINE CONTAINING ACELLULAR PERTUSSIS COMPONENT Article gives a brief characteristic of new three- or four-component vaccine with acellular pertussis component INFANTRIX or INFANTRIX HIB manufactured by GlaxoSmithKline company, which is less reactogenic than so far used vaccine with cellular pertussis component, and which is determined for children until 6 years of age (7th birthday) with neurological risk or for children after febrile convulsions. It is also recommended for children, which had general reaction after the vaccination with cellular pertussis vaccine characterised with temperature above 38,5 °C and accompanied with marked restlessness or possibly with so-called unsatisfiable cry. There are also mentioned contraindications to vaccination against pertussis in children with neurological disease. Key words: vaccination, pertussis, neurological risks, indication, contraindication.